These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study. Bortlik M; Machkova N; Duricova D; Malickova K; Hrdlicka L; Lukas M; Kohout P; Shonova O; Lukas M Scand J Gastroenterol; 2013 Aug; 48(8):951-8. PubMed ID: 23834232 [TBL] [Abstract][Full Text] [Related]
3. Systemic Mycobacterium avium complex infection during antitumor necrosis factor-α therapy in pediatric Crohn disease. Jordan N; Waghmare A; Abi-Ghanem AS; Moon A; Salvatore CM J Pediatr Gastroenterol Nutr; 2012 Feb; 54(2):294-6. PubMed ID: 21694635 [No Abstract] [Full Text] [Related]
4. Safety of infliximab use during pregnancy. Djokanovic N; Klieger-Grossmann C; Pupco A; Koren G Reprod Toxicol; 2011 Jul; 32(1):93-7. PubMed ID: 21621603 [TBL] [Abstract][Full Text] [Related]
5. Cutaneous pseudolymphoma caused by tumor necrosis factor-α inhibitors was not induced by ustekinumab. Imafuku S; Tatsukawa R; Ito K; Nakayama J J Dermatol; 2012 Dec; 39(12):1070. PubMed ID: 22698067 [No Abstract] [Full Text] [Related]
6. Pregnant women with inflammatory bowel disease: the effects of biologicals on pregnancy, outcome of infants, and the developing immune system. Wieringa JW; Driessen GJ; Van Der Woude CJ Expert Rev Gastroenterol Hepatol; 2018 Aug; 12(8):811-818. PubMed ID: 29972674 [TBL] [Abstract][Full Text] [Related]
7. [1/2 The anti-TNF alpha drugs]. Medjoub M; Limat S; Woronoff-Lemsi MC Soins; 2007 Oct; (719):59-61. PubMed ID: 18020248 [No Abstract] [Full Text] [Related]
8. Anti-TNF-alpha therapy for orofacial granulomatosis: proceed with caution. Gaya DR; Aitken S; Fennell J; Satsangi J; Shand AG Gut; 2006 Oct; 55(10):1524-5. PubMed ID: 16966709 [No Abstract] [Full Text] [Related]
11. Fatal invasive pulmonary aspergillosis associated with adalimumab therapy. Manz M; Beglinger C; Vavricka SR Gut; 2009 Jan; 58(1):149. PubMed ID: 19091839 [No Abstract] [Full Text] [Related]
12. Tumour necrosis factor-alpha and tuberculosis: guidance from the National TB Advisory Committee. Kavanagh PM; Gilmartin JJ; O'Donnell J; O'Flanagan D Ir Med J; 2008 Jan; 101(1):6-7. PubMed ID: 18369014 [No Abstract] [Full Text] [Related]
13. High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy. Zelinkova Z; de Haar C; de Ridder L; Pierik MJ; Kuipers EJ; Peppelenbosch MP; van der Woude CJ Aliment Pharmacol Ther; 2011 May; 33(9):1053-8. PubMed ID: 21366638 [TBL] [Abstract][Full Text] [Related]
17. Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease. Herrinton LJ; Liu L; Weng X; Lewis JD; Hutfless S; Allison JE Am J Gastroenterol; 2011 Dec; 106(12):2146-53. PubMed ID: 22031357 [TBL] [Abstract][Full Text] [Related]
18. First case report of adalimumab-induced psoriasis in Crohn's disease. Harris MD; Richards R Am J Gastroenterol; 2009 Mar; 104(3):792-3. PubMed ID: 19262532 [No Abstract] [Full Text] [Related]
19. Development of miliary tuberculosis related to anti-tumor necrosis factor-alpha inhibitor therapy for pustular psoriasis. Koga M; Terawaki S; Tatsukawa R; Fujita M; Imafuku S; Nakayama J J Dermatol; 2013 Jun; 40(6):476-7. PubMed ID: 23731475 [No Abstract] [Full Text] [Related]
20. Tumor necrosis factor inhibition and glucose homeostasis. Larsen AJ; Clarke JT J Am Acad Dermatol; 2013 Jun; 68(6):e182-3. PubMed ID: 23680212 [No Abstract] [Full Text] [Related] [Next] [New Search]